Our member MiSSis was in Southern California this week from Illinois. Even though we didn't get to meet, we had a great phone conversation. One thing we discussed was high cholesterol and transplant recipients. She got me thinking so I looked up more info. Doctor's seem to downplay this type of thing, I think because Jenna is so young. But the longterm effects need to be monitored to keep her healthy for a long time.
Thanks MISSis - I always learn things from our members!
High CholesterolMany immunosuppressant drugs can contribute to high cholesterol. This condition therefore affects many transplant recipients. When a patient develops high cholesterol, blood vessels, including the ones attached to the transplanted organ, become clogged, which affects the flow of blood. This slowing of blood flow can affect the success of your transplant and may even lead to heart disease. It is important to talk to your doctor about how to reduce the risk factors of heart disease, including controlling your cholesterol.
Testing Your Cholesterol Levels
High blood cholesterol itself does not have warning signs or symptoms, and as a result many people are unaware that their
cholesterol level is too high. A lipid profile blood test is recommended to find out your cholesterol numbers. This test gives you information
about your:
•Total cholesterol
•LDL (bad) cholesterol
•HDL (good) cholesterol
•Triglycerides
This info is from: "Staying Healthy With Your New Transplant"
http://www.transplantliving.org/afterthetransplant/stayinghealthy/healthconcerns.aspxNews article from 2005:
Statins may help shield organ recipients from heart attackSATURDAY, Nov. 12 (HealthDay News) -- Giving cholesterol-lowering statin drugs to kidney transplant recipients may reduce their increased risk of heart attack and other cardiovascular events, a Norwegian study found.
"As patients continue to live longer after kidney transplantation, there is an increased need to prevent some of the long-term complications that can develop. One major risk is premature cardiovascular disease, related to high cholesterol levels developing after transplantation," study leader Dr. Hallvard Holdaas of National Hospital in Oslo, said in a prepared statement.
The study included more than 2,100 kidney transplant recipients divided into two groups. One group received the cholesterol-lowering drug fluvastatin for up to eight years, while the other group received a placebo. All the patients in the study had good long-term functioning of their transplanted kidney.
In the group taking fluvastatin, the average level of so-called "bad" low-density lipoprotein (LDL) cholesterol decreased from 159 milligrams per deciliter (mg/dL) to 98 mg/dL. These patients also achieved a 21 percent reduction in their risk of heart attack and other major cardiovascular events, while their combined risk of death from cardiac causes decreased by 29 percent, compared to patients taking the placebo.
Both groups had a similar overall risk of death from all causes and similar rates of long-term survival of the transplanted kidney.
The study was presented Nov. 11 at the American Society of Nephrology annual meeting, in Philadelphia.
..........
There's an article I posted that discusses the Kidney and Heart
http://ihatedialysis.com/forum/index.php?topic=4127.0